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A number of observations in the last few years
have attracted attention to the possibility of viral
infection in systemic lupus erythematosus ( SLE).
One of these is the occurrence of interwoven tubular
structures, usually in the endothelial cells of the
kidney but also in the lymphocytes and in fibroblasts
when SLE skin fibroblasts are cultured. These tubular structures have resembled viruses (they were
thought by thei~ discoverers to be myxo- or paramyxoviruses), but it has been argued ( 1) that
they are not viruses because of their size and appearance and because they have been produced in
tissue cultures from subjects who do not have SLE;
they occur in many other conditions which are not
related to SLE. These tubular structures do not
occur, however, in rheumatoid arthritis (RA). The
conclusion, at this point, would seem to be that
they are not viruses. Nevertheless, from their randomness and their odd app,earance, it seems likely
that we may be seeing the effects of a virus, perhaps a very common ¥irus, on the endoplasmic
reticulum of the cell.
There has been a group of papers in which the
point has been made (2, 3, 4) that the titers of a
number of viral antibodies (usually myxo- and paramyxoviruses) am somewhat elevated in patients
with SLE. It has been argued that this simply
represents the overall hyper-y-globulinemia of SLE,
although we have not noted the relationship with
y-globulin levels. It should be pointed out that there
has been no outstanding elevation of any particular
viral antibody titer. The antibody titer to measles,
an RNA virus, has been consistently elevated to a
significant degree. This may mean that antibody to
this virus cross-reacts well with an unidentified RN A
virus which is actually involved.

* Presented by Dr. Ziff at the 45th Annual McGuire
Lecture Series, November 9, 19'73, at the Medical College
of Virginia, Richmond.
MCV QUARTERLY 10(2): 57-60, 1974

Cellular Immunity in SLE. Hahn and coworkers ( 5) have reviewed the evidence for reduced delayed hypersensitivity in SLE. About half
of investigators have noted decreased skin test reactions in this disease. Patients with SLE also tend
to develop lymphomas somewhat more commonly
than expected. Presumably these patients do not
have adequate immunologic surveillance for rejection of lymphomas on the basis of diminished cellular immunity.
Regarding cellular immunity, it is known that
thymus-derived lymphocytes undergo blastic transformation and produce lymphokines. When the T
cell has been stimulated, it can also subserve the
antigen to stimulate B lymphocytes (bone marrowderived) to produce antibody.
With regard to the possible role of a virus in
SLE and the fact that depressed cellular immunity
seems to be present, it is fairly well accepted that
virus infections, in general, decrease delayed hypersensitivity as measured by skin tests and by the
response of the circulating T cells of the infected
patient to mitogens like PHA and concanavalin.
Also, if one adds a virus like rubella to lymphocyte
cultures, the capacity of the T cells in that culture
to undergo a response to mitogenic agents is diminished.
As is well known, the New Zealand Black
(NZB) mouse, particularly its F 1 hybrid, is an
excellent model for SLE. The NZB F 1 hybrid mouse
has also been shown to have decreased cellular
immunity ( 6). It has a decreased capacity to induce graft-versus-host disease in a recipient mouse
strain. There is also a decreased responsiveness to
mitogenic agents and a high incidence of lymphomas.
For unexplained reasons, T cells in man form
rosettes with sheep red blood cells. These rosettes
represent a measure of the T cells circulating in the
blood. Wybran and Fudenberg (7), using this
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method, found that patients with viral infections
have reduced numbers of circulating T lymphocytes.
In our laboratory, Drs. Hurd and Giuliano have
observed decreased numbers of spontaneous rosetteforming cells in patients with SLE suggesting decreased cellular immunity. This could be a result of
coating with an immunosuppressive globulin or a
true deficiency of T cells.
Autoantibody Formation. It should be pointed
out that in SLE, we are concerned not as much with
T cell function as with the results of B cell activity
since these cells produce autoantibodies such as antiDNA, both double- and single-stranded, antinuclear
antibody, anti-RNA, both double- and singlestranded, as well as other types of autoantibodies.
Are such autoantibodies found in virus infections?
Two conditions stand out-one, infectious mononucleosis, an EB virus infection, and the other,
cytomegalovirus infection. In these conditions, we
see antinuclear antibody, rheumatoid factor, mixed
cryoglobulins, Coombs autoantibodies, and so forth.
The NZB mice are infected with murine leukemia viruses. This strain, unlike other strains, does
not develop tolerance to the murine leukemia viruses
and eventually develops antibodies to these viruses.
These form immune complexes which circulate in
the blood and in time the mice develop proteinuria.
The immune complexes eventually deposit in the
basement membrane of the kidney. If NZB F 1
hybrids are injected with nonleukemogenic viruses
such as LCM, which is an RNA virus, or with
polyoma, which is a DNA virus, antinuclear antibody is enhanced, the glomerulonephritis is aggravated and the mortality rate goes up ( 8). These
viruses, it appears, exert an adjuvant effect in stimulating autoantibody formation. Nucleic acids are
known to have adjuvant effects. Weight for weight,
the RNA of the tubercle bacillus is as effective an
adjuvant as the tubercle bacillus itself (9). Powell
and Steinberg (10) have examined the adjuvant
effects in the NZB-NZW mouse of poly I-poly C,
a synthetic double-stranded RNA, and have found
an increase in antibody, not only to double-stranded
RNA, but also an increase to DNA. Cone and
Johnson (11) have shown that poly A-poly U increased the antibody response against sheep red
blood cells. One may speculate from these kinds
of results that the viral nucleic acids may also have
an adjuvant effect on both antibody and autoantibody formation .
It appears likely that if a virus were to be the

cause of SLE, it would be so by affecting T lymphocyte
function. In our laboratory ( 12), we have demonstrated that T cells produce a relatively low molecular weight factor, which has a stimulatory effect on
antibody formation by B cells. Fialkow, Gilchrist
and Allison ( 13) have shown that T cell stimulation
can lead to autoantibody formation. F 1 hybrid mice
injected with parental cells undergo a graft-versushost reaction in which the donor T cells proliferate.
These mice develop antinuclear antibody after each
injection of T cells, presumably because of the
elaboration of a helper factor by the proliferating T
cells.
There is also evidence that a suppressor population of T cells exists which presumably inhibits
autoantibody formation. The first evidence for suppressor T cells came from our laboratory ( 14) in
a study of the effect of antilymphocyte globulin on
the immune response of rabbits. When rats were
treated with this agent, the antibody response to
keyhole limpet hemocyanin was increased instead
of reduced. This result has been interpreted by
others (15) to indicate that there is a type of T
cell whose function is to suppress the antibody
response. Subsequently, Baker and co-workers ( 16)
showed that there was an increased response to
pneumococcal polysaccharide in mice upon treatment with antithymocyte serum.
Recently, Steinberg and co-workers ( 17)
showed that neonatal thymectomy of NZB mice
accelerated the formation of anti-DNA antibodies
and that this change could be reversed by grafting
these mice with one-week old thymuses, but not
with ten-week old thymuses. Suppressor T cells
presumably are lost in the NZB F 1 hybrid at an
early age. This seems to be the cause of the aggravated form of the disease observed in thymectomized
animals.
It is well established that autoantibodies develop
in the aged ( 18). Phytohemagglutinin responsiveness, which is a measure of T cell function, also decreases. These changes may reflect a loss of suppressor T cells with age in man. When Teague and Friou
( 19) administered syngenic thymocytes from young
mice to older mice who were producing antinuclear
antibodies, these antibodies disappeared, suggesting
that suppressor T cell function had been restored.
The explanation for these phenomena, most clearly
enunciated by ·Allison ( 20), is that we are dealing
with a particular type of tolerance in the normal
state which does not permit autoantibodies to form.
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This tolerance resides in the T cell, as originally suggested by Weigle (21). The B cells which produce
antoantibody are not tolerant and when they are
stimulated by helper substance from helper T cells
or freed from the suppressive action of suppressor
T cells, they become free to synthesize autoantibody
in the presence of autoantigen. In speculating about
the role of a virus in autoimmune phenomena, one
might suppose that an infected individual would have
T cells sensitized to the causative virus, whatever
virus that might be. This virus could then stimulate these sensitized T cells to produce a helper
substance. As a result, potentially responsive
(nontolerant) B cells would gain the capacity to
produce autoantibodies. Thus, viruses might act as
adjuvants for autoantibody formation by stimulating
sensitized T cells to produce helper substances,
which could then stimulate B cells to produce autoantibody in the presence of autoantigen. They could
also interfere in some unexplained manner with the
suppressor effect of suppressor T cells by producing
a broad interference with T cell function since, as
mentioned, T cell levels are, in fact, low in the virus
diseases ( 7 ) .
Another interesting line of evidence which
should be mentioned comes from the studies of
Lewis and co-workers (22) who have injected
filtered suspensions of spleens of dogs with SLE
to CA F 1 mice. These mice have, as a result, developed antinuclear antibodies. This finding suggests
the presence of a filterable agent, probably a virus,
in the affected donor dogs, having the capacity to
produce antinuclear antibodies.
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